Investview, Inc (INVU) Fair Value & Analysis
Technology · US · Market cap $39.5M
Fair value as of: Jun 24, 2026
Analysis
Investview, Inc (INVU) currently trades at $0.0214, while our model-based Fair Value estimate is $0.0100 — implying the stock looks roughly 53.3% overvalued today. We read business quality at 95/100 (high quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
About the company
Investview, Inc., through its subsidiaries, operates as a financial technology services company in the United States and internationally. It operates through three segments: Direct-to-Consumer Marketing Platform; Blockchain Technology and Crypto Mining Products and Services; and Manufacturing and Development of Health, Beauty, and Wellness Products. The company's financial education division offers tools, products, and content through a global network of independent distributors. Its manufacturing division provides proprietary over-the-counter aesthetics, health, nutrition, and cognitive wellness products for the wholesale and retail markets. The company also owns and operates an early-stage online trading platform that intends to offer self-directed retail brokerage services; and a blockchain business focused on bitcoin mining. Investview, Inc. was founded in 1946 and is headquartered in Haverford, Pennsylvania.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Investview, Inc (INVU) undervalued?
What is the fair value of INVU?
What is the quality score of INVU?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.